Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ADESHWAR MEDITEX vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ADESHWAR MEDITEX ASTRAZENECA PHARMA ADESHWAR MEDITEX/
ASTRAZENECA PHARMA
 
P/E (TTM) x - 191.9 - View Chart
P/BV x 1.0 22.2 4.4% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ADESHWAR MEDITEX   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ADESHWAR MEDITEX
Mar-24
ASTRAZENECA PHARMA
Mar-24
ADESHWAR MEDITEX/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs367,208 0.5%   
Low Rs163,102 0.5%   
Sales per share (Unadj.) Rs55.3518.2 10.7%  
Earnings per share (Unadj.) Rs1.464.6 2.2%  
Cash flow per share (Unadj.) Rs1.870.6 2.6%  
Dividends per share (Unadj.) Rs024.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs24.2283.5 8.5%  
Shares outstanding (eoy) m14.4325.00 57.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.59.9 4.7%   
Avg P/E ratio x18.879.8 23.5%  
P/CF ratio (eoy) x14.473.0 19.8%  
Price / Book Value ratio x1.118.2 5.9%  
Dividend payout %037.1 0.0%   
Avg Mkt Cap Rs m377128,875 0.3%   
No. of employees `000NANA-   
Total wages/salary Rs m122,415 0.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m79912,955 6.2%  
Other income Rs m1348 0.4%   
Total revenues Rs m80013,303 6.0%   
Gross profit Rs m522,009 2.6%  
Depreciation Rs m6149 4.0%   
Interest Rs m1912 160.5%   
Profit before tax Rs m282,195 1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8580 1.3%   
Profit after tax Rs m201,615 1.2%  
Gross profit margin %6.515.5 41.8%  
Effective tax rate %27.926.4 105.6%   
Net profit margin %2.512.5 20.2%  
BALANCE SHEET DATA
Current assets Rs m57110,427 5.5%   
Current liabilities Rs m2774,672 5.9%   
Net working cap to sales %36.844.4 82.8%  
Current ratio x2.12.2 92.3%  
Inventory Days Days1547 31.5%  
Debtors Days Days1,15543 2,677.6%  
Net fixed assets Rs m682,342 2.9%   
Share capital Rs m14450 288.6%   
"Free" reserves Rs m2057,036 2.9%   
Net worth Rs m3497,086 4.9%   
Long term debt Rs m110-   
Total assets Rs m63912,769 5.0%  
Interest coverage x2.4184.0 1.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.21.0 123.2%   
Return on assets %6.212.7 48.3%  
Return on equity %5.822.8 25.2%  
Return on capital %13.131.2 42.0%  
Exports to sales %6.20-   
Imports to sales %00.5 0.0%   
Exports (fob) Rs m50NA-   
Imports (cif) Rs mNA61 0.0%   
Fx inflow Rs m501,094 4.5%   
Fx outflow Rs m061 0.0%   
Net fx Rs m501,033 4.8%   
CASH FLOW
From Operations Rs m38279 13.8%  
From Investments Rs m-2217 -1.0%  
From Financial Activity Rs m-44-444 9.8%  
Net Cashflow Rs m-752 -14.3%  

Share Holding

Indian Promoters % 57.6 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 8.0 -  
FIIs % 0.0 2.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 42.5 25.0 169.8%  
Shareholders   182 27,615 0.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ADESHWAR MEDITEX With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ADESHWAR MEDITEX vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ADESHWAR MEDITEX vs ASTRAZENECA PHARMA Share Price Performance

Period ADESHWAR MEDITEX ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 0.00% -3.21% 0.11%
1-Month 0.26% -14.94% -3.22%
1-Year -5.76% 34.32% 42.65%
3-Year CAGR -8.74% 27.98% 19.86%
5-Year CAGR -1.30% 18.49% 25.90%

* Compound Annual Growth Rate

Here are more details on the ADESHWAR MEDITEX share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of ADESHWAR MEDITEX hold a 57.6% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ADESHWAR MEDITEX and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, ADESHWAR MEDITEX paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ASTRAZENECA PHARMA paid Rs 24.0, and its dividend payout ratio stood at 37.1%.

You may visit here to review the dividend history of ADESHWAR MEDITEX, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.